(Q40606402)

English

Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation

scientific article published on April 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lee JH

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Lee KH

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Kim S

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Seol M

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Kim SH

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Kim WK

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Lee JS

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Leukemia Research

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

305-312

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia. Gruppo Italiano Trapianto di Midollo Osseo

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete remission following donor PBSC after low-dose cytarabine chemotherapy for early relapse of acute myelogenous leukemia after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute and chronic graft-versus-host disease in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Extramedullary relapse after favorable molecular response to donor leukocyte infusions for recurring acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900142-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0145-2126(00)00142-9

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40606402&oldid=1903621506"